Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
NiQuitin 7mg patches
0410020B0BDACAP
|
NiQuitin | Nicotine | Central Nervous System | 546 |
|
Reltebon 5mg modified-release tablets
0407020ADBKAAAK
|
Reltebon | Oxycodone hydrochloride | Central Nervous System | 546 |
|
NiQuitin Minis Mint 4mg lozenges
0410020B0BDANAZ
|
NiQuitin | Nicotine | Central Nervous System | 543 |
|
Nefopam 60mg tablets
0407010P0AAAGAG
|
Nefopam hydrochloride | Nefopam hydrochloride | Central Nervous System | 542 |
|
Phenobarbital 15mg/5ml elixir
0408010N0AAACAC
|
Phenobarbital | Phenobarbital | Central Nervous System | 542 |
|
Caramet 25mg/100mg CR tablets
0409010N0BEAAAG
|
Caramet | Co-careldopa (Carbidopa/levodopa) | Central Nervous System | 541 |
|
Nicorette Freshmint 4mg medicated chewing gum
0410020B0BBAQBD
|
Nicorette | Nicotine | Central Nervous System | 541 |
|
Oxylan 5mg prolonged-release tablets (G.L. Pharma UK Ltd)
0407020ADBFAAAK
|
Oxylan | Oxycodone hydrochloride | Central Nervous System | 541 |
|
Dihydrocodeine 40mg tablets
0407020G0AAAIAI
|
Dihydrocodeine tartrate | Dihydrocodeine tartrate | Central Nervous System | 538 |
|
Ondansetron 8mg orodispersible tablets
0406000S0AAALAL
|
Ondansetron hydrochloride | Ondansetron hydrochloride | Central Nervous System | 538 |
|
Trazodone 100mg/5ml oral solution sugar free
0403010X0AAANAN
|
Trazodone hydrochloride | Trazodone hydrochloride | Central Nervous System | 538 |
|
Hyoscine hydrobromide 150microgram chewable tab sugar free
0406000L0AAAWAW
|
Hyoscine hydrobromide (Systemic) | Hyoscine hydrobromide | Central Nervous System | 537 |
|
Zamadol SR 50mg capsules
040702040BDABAG
|
Zamadol | Tramadol hydrochloride | Central Nervous System | 536 |
|
Fentanyl 200microgram lozenges
0407020A0AAAIAI
|
Fentanyl | Fentanyl | Central Nervous System | 535 |
|
Melatonin 2.5mg/5ml oral solution
0401010ADAACFCF
|
Melatonin | Melatonin | Central Nervous System | 533 |
|
Avomine 25mg tablets
0406000V0BBAAAA
|
Avomine | Promethazine teoclate | Central Nervous System | 532 |
|
Oxycodone 40mg / Naloxone 20mg modified-release tablets
0407020AFAAADAD
|
Oxycodone hydrochloride/naloxone hydrochloride | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | 532 |
|
Alzain 300mg capsules
0408010AEBEAHAG
|
Alzain | Pregabalin | Central Nervous System | 528 |
|
OxyContin 15mg modified-release tablets
0407020ADBCAIAS
|
OxyContin | Oxycodone hydrochloride | Central Nervous System | 520 |
|
Paliperidone 6mg modified-release tablets
0402010AEAAABAB
|
Paliperidone | Paliperidone | Central Nervous System | 519 |
|
Haldol 2mg/ml oral solution
0402010J0BDACAG
|
Haldol | Haloperidol | Central Nervous System | 517 |
|
Paravict 500mg tablets
0407010H0CUAAAM
|
Paravict | Paracetamol | Central Nervous System | 507 |
|
Arlevert tablets
0406000ACBBAAAA
|
Arlevert | Dimenhydrinate/cinnarizine | Central Nervous System | 506 |
|
Levodopa 200mg / Carbidopa 50mg / Entacapone 200mg tablets
0409010X0AAADAD
|
Levodopa/carbidopa/entacapone | Levodopa/carbidopa/entacapone | Central Nervous System | 506 |
|
Motilium 10mg tablets
0406000J0BBAEAJ
|
Motilium | Domperidone | Central Nervous System | 505 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.